MMP9 also interacts with the tumor matrix via cleaving laminin and aggrecan and ultimately increases the bioavailability of vascular endothelial growth factor (VEGF) during the angiogenic switch.13 This is consistent with our findings of enriched MMP9 expression in both perivascular regions and tumor parenchyma. This evidence concerns the gene VEGFA and neoplasm.